Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMR”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Post-approval studies (Phase 4)Looking for participantsNCT05979545
What this trial is testing

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Who this might be right for
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
National University of Singapore 1,900
Not applicableLooking for participantsNCT07261969
What this trial is testing

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

Who this might be right for
Respiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR+2 more
Rigshospitalet, Denmark 1,050
Not applicableEnrolling By InvitationNCT07818109
What this trial is testing

One Health Determinants of Rectal Colonization by ESBL-Producing Enterobacterales in the Community

Who this might be right for
Antimicrobial Resistance (AMR)ESBLGut Microbiota Dysbiosis+4 more
Hospital Italiano de Buenos Aires 432
Large-scale testing (Phase 3)Study completedNCT00660504
What this trial is testing

Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 300
Not applicableStudy completedNCT07189429
What this trial is testing

Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting

Who this might be right for
UTI - Urinary Tract InfectionUTI - Lower Urinary Tract InfectionAMR+2 more
Sysmex Europe GmbH 199
Not applicableStudy completedNCT07570927
What this trial is testing

Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine Use

Who this might be right for
Antimicrobial Resistance (AMR)Oral MicrobiotaOral Microbiome Health+2 more
Masaryk University 11
Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Not applicableStudy completedNCT05305534
What this trial is testing

QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

Who this might be right for
Blood Disease
QIAGEN Gaithersburg, Inc 2,142
Early research (Phase 1)Study completedNCT00915083
What this trial is testing

A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Celgene 24
Not applicableNot Yet RecruitingNCT07618702
What this trial is testing

Efficacy and Safety of Modified ORS(Amr and Khulood ORS) in Diabetic Pilgrims During Hajj

Who this might be right for
Diabetes MellitusHeat Stress
Amr kamel khalil Ahmed 200
Not applicableUnknownNCT06430775
What this trial is testing

Exploring Prolonged AMR in ACL Reconstructed Patients

Who this might be right for
Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament RuptureAnterior Cruciate Ligament Tear+6 more
University Ghent 190
Not applicableStudy completedNCT05378217
What this trial is testing

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

Who this might be right for
Bacterial Sensitivity TestsAntimicrobial Drug Resistance
Assistance Publique - Hôpitaux de Paris 167
Not applicableLooking for participantsNCT06717594
What this trial is testing

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE

Who this might be right for
Gram Negative InfectionsAntimicrobial Resistance (AMR)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableUnknownNCT04217343
What this trial is testing

NCAMR-CAMR Allosure Study

Who this might be right for
Transplant Failure
Tampa General Hospital 30
Early research (Phase 1)Study completedNCT00890955
What this trial is testing

Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies

Who this might be right for
Lung Cancer
Lawrence Einhorn 36
Large-scale testing (Phase 3)Enrolling By InvitationNCT07444489
What this trial is testing

Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

Who this might be right for
Antibody-mediated RejectionMicrovascular Inflammation
Biogen 201
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Not applicableLooking for participantsNCT06651047
What this trial is testing

PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections

Who this might be right for
Gram Negative InfectionAntimicrobial Resistance (AMR)
University of Bologna 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing

Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant

Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36
Next Page